FitRx will work to ship your medication for as little as $151/month
Chen Q, Anijs RJS, Verlaan JPL, Scheres LJJ, Klok FA, Cannegieter SC (2025) Novel antidiabetic drugs and risk of venous thromboembolism: a literature review
A landmark study published in the New England Journal of Medicine found that participants taking semaglutide (Wegovy) lost an average of nearly 15% of their body weight over 68 weeks approximately three times the weight loss seen with placebo
The "right model" is access with guardrails, qualified clinicians, licensed pharmacies, validated quality testing and "meaningful" patient follow-up, according to the expert
At the end of the day, if youre trying to lose weight, consult a doctor before trying a new strategy or supplement no matter how promising it appears